ImmunoMet Therapeutics
Latest round
- Series B
Last raised
- Mar 2017
Total raised
- $10M
Investors
- 7
About ImmunoMet Therapeutics
Founded in 2015 and based in Houston, Texas, ImmunoMet Therapeutics, Inc. operates as a biopharmaceutical company, developing anti-tumor and immuno-oncology therapies.
Who invested in ImmunoMet Therapeutics
7 investors across 2 rounds
See all investors in ImmunoMet Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImmunoMet Therapeutics
Who invested in ImmunoMet Therapeutics?
ImmunoMet Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmunoMet Therapeutics raised?
ImmunoMet Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ImmunoMet Therapeutics last raise money?
ImmunoMet Therapeutics's most recent round on record is a Series B, in Mar 2017.
What does ImmunoMet Therapeutics do?
Founded in 2015 and based in Houston, Texas, ImmunoMet Therapeutics, Inc.
Where is ImmunoMet Therapeutics headquartered?
ImmunoMet Therapeutics is headquartered in Houston, US.
Which VCs invest in companies like ImmunoMet Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ImmunoMet Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ImmunoMet Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.